the value of medication therapy management services l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
The Value of Medication Therapy Management Services PowerPoint Presentation
Download Presentation
The Value of Medication Therapy Management Services

Loading in 2 Seconds...

play fullscreen
1 / 34

The Value of Medication Therapy Management Services - PowerPoint PPT Presentation


  • 227 Views
  • Uploaded on

The Value of Medication Therapy Management Services. Purpose of Medication Therapy Management Services (MTMS). To optimize therapeutic outcomes To decrease the likelihood of adverse events To enhance patient understanding and adherence To reduce overall healthcare spending.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'The Value of Medication Therapy Management Services' - Sophia


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
purpose of medication therapy management services mtms
Purpose of Medication Therapy Management Services (MTMS)
  • To optimize therapeutic outcomes
  • To decrease the likelihood of adverse events
  • To enhance patient understanding and adherence
  • To reduce overall healthcare spending

APhA. Pharmacists Improving Care and Reducing Costs for Your Plan Participants. Available at: www.pharmacist.com

definition of mtms
Definition of MTMS
  • Services provided by a pharmacist that improve treatment outcomes for individual patients
  • A professional service to promote the safe and effective use of medications
  • A way to provide better care for patients
    • Promotes collaboration among the patient, the pharmacist, and the patient’s other health care providers

.

Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc. 2005;45:566–72

mtms activities
MTMS Activities
  • Assess patients’ health status
  • Devise a medication treatment plan
  • Select, modify and administer medications
  • Review current medications and identify drug-related problems
  • Communicate care to other providers
  • Provide patient education
  • Refer patients for broader disease management services

APhA. Pharmacists Improving Care and Reducing Costs for Your Plan Participants. Available at: www.pharmacist.com

the spectrum of pharmacist provided mtms
The Spectrum of Pharmacist-Provided MTMS
  • Comprehensive or Targeted Medication Therapy Reviews
  • Adherence Services
    • Based on the number and/or type of medications
  • Targeted Medication Intervention Programs
    • High-alert and/or high-cost medications
    • Targeted patient population (i.e. geriatrics, pediatrics)
  • Disease State Management
    • Interdisciplinary approach to achieve therapeutic goals
    • Example disease states: Diabetes, Dyslipidemia, Asthma
  • Health and Wellness Services
    • Immunizations
    • Wellness screenings
    • Smoking cessation
    • Weight management

APhA. Pharmacists Improving Care and Reducing Costs for Your Plan Participants. Available at: www.pharmacist.com

components of the mtms core elements service model
Components of the MTMS Core Elements Service Model
  • Medication Therapy Review (MTR)
    • a review of all medications including prescription, nonprescription, herbal products, and other dietary supplements
  • Personal Medication Record (PMR)
  • Medication-Related Action Plan (MAP) for the patient
  • Intervention and/or Referral
  • Documentation and Follow-Up

APhA. Pharmacists Improving Care and Reducing Costs for Your Plan Participants. Available at: www.pharmacist.com

value of a personal medication record
Value of a Personal Medication Record

“The medication record helps give the doctors a better picture of what’s going on with me.”

value of mtms
Value of MTMS

“Having the help of a person who specializes in medications, which impacts me on a daily basis—putting drugs in my body.”

physicians value mtm pharmacists
Physicians Value MTM Pharmacists

“Working with the MTM Pharmacist has helped me to focus on the things that only I can do as a physician.”

slide10

Medication Therapy Management Process

ASSESSMENT

 Evaluate appropriateness, effectiveness, safety, and compliance with medications

 Identify drug therapy problems

Patient

Practitioner

CARE PLAN

Experienced Decision Making

Medication Experience

 Resolve drug therapy problems

 Establish goals of therapy

 Interventions

 Philosophy of Practice

 Social Obligation

 Responsibility to

identify, resolve,

and prevent

drug therapy

problems

 Patient-centered

approach

 Caring

 Today’s wants

and needs

 Responsibility

to participate

in information

sharing and

decision making

FOLLOW-UP

 Evaluate progress in meeting goals of therapy

 Record actual patient outcomes

 Reassess new problems

Therapeutic Relationship

pharmacist s communication with other health providers
Pharmacist’s Communication with Other Health Providers
  • MTM Pharmacists will communicate regularly with patient’s primary care provider, and other health care team members as appropriate
    • Describe assessment
    • Describe and rationalize recommendations for medication changes
    • Recommendations for follow-up
how do we define value
How Do We Define Value?
  • Value on investment
    • Economic
      • Overall cost savings or cost
    • Clinical
      • Improvements in health outcomes
    • Humanistic
      • Patient satisfaction, improved quality of life, worker productivity
studies illustrating value of mtms
Studies Illustrating Value of MTMS
  • Asheville Project: Diabetes
  • Asheville Project: Asthma
  • Diabetes Ten City Challenge
  • Minnesota Experience Project
asheville project diabetes
Asheville Project: Diabetes
  • Evaluation of outcomes following community based provision of MTMS to patients with diabetes covered by a self-insured employer group (City of Asheville, NC and Mission-St. Joseph’s Health System)
  • Longitudinal study with pre- and post- data
  • Participants were provided incentives including waiver of all copays for diabetes medications and supplies
  • 5 years of follow-up data
  • 187 participants entered the program, with 26 continuing at 5 years

Cranor CW, Bunting BA, Christensen DB. J Am Pharm Assoc. 2003;43:173–84.

key findings asheville diabetes
Key Findings: Asheville Diabetes
  • Economic benefit
    • Total health care costs for patients decreased (after 5 years, an average of $3,356 per patient per month savings)
    • Prescription costs increased, but medical costs decreased
  • Clinical benefit
    • Significant improvement seen in A1C (7.6% baseline vs. 6.2% after 14 months, p<0.05) and LDL (118mg/dl baseline vs. 98mg/dl after 14 months, p<0.05)
  • Humanistic benefit
    • Decreased sick leave; increased worker productivity

Cranor CW, Bunting BA, Christensen DB. J Am Pharm Assoc. 2003;43:173-84.

asheville project asthma
Asheville Project: Asthma
  • Evaluation of outcomes following community based provision of MTMS to patients with asthma covered by a self-insured employer group (City of Asheville, NC and Mission-St. Joseph’s Health System)
  • Longitudinal study with pre- and post- data
  • Participants were provided incentives including waiver of all copays for asthma medications and supplies
  • 5 years of follow-up data
  • 207 participants entered the program

Bunting BA, Cranor CW. JAPhA. 2006; 46:133-147.

key findings asheville asthma
Key Findings: Asheville Asthma
  • Economic benefit
    • Decreased percentage of asthma patients requiring emergency (9.9% to 1.3%) and hospital care (4.0% to 1.9%)
    • An average decrease in costs of $725/patient/year
  • Clinical benefit
    • Improved asthma control sustained over 5 years

(as evidenced by FEV1 measurements)

Bunting BA, Cranor CW. JAPhA. 2006; 46:133-147.

diabetes ten city challenge
Diabetes Ten City Challenge
  • Employer-funded, collaborative health management program for diabetes using community-based pharmacists in 10 cities across the USA
    • Pharmacists were located in:
      • Independent pharmacies
      • Chain pharmacies
      • Ambulatory care clinics
      • On-site workplace locations
  • Participants received waived co-pays for medications
  • 573 patients participated

Fera T., Bluml BM, Ellis WM. JAPhA. 2009; 49(3): 383-391.

key findings 10 city challenge
Key Findings: 10 City Challenge
  • Economic benefit
    • Total health care costs were less than predicted (7.24% less than predicted)
    • Prescription costs increased, but overall health care

costs decreased

  • Clinical benefit
    • Increased percentage of patients meeting HEDIS process measurement goals for patients with diabetes

Fera T., Bluml BM, Ellis WM. JAPhA. 2009; 49(3): 383-391.

minnesota experience project
Minnesota Experience Project
  • Evaluation of MTMS provided at 6 ambulatory care clinics over 1 year
  • 285 patients received MTMS
  • HEDIS goals for hypertension and dyslipidemia were evaluated
  • Study patients were required to have 1 of 12 study conditions
  • Return on investment was calculated at 12:1

Isetts, et al., J Am Pharm Assoc. 2008;48(2):203-211

key findings minnesota experience project
Key Findings: Minnesota Experience Project
  • Economic benefit
    • A 12:1 return on investment was seen
    • Savings was seen in facilities costs
    • Per person per year costs decreased from $11,965 to $8,197
  • Clinical benefit
    • The MTM intervention group had a higher percentage of patients meeting HEDIS goals for hypertension and dyslipidemia
limitations of current evidence
Limitations of Current Evidence
  • Most of the data comes from self-insured employer groups
  • Individual studies are small
    • Ten City Challenge was the largest with 573 participants
  • Much of the evidence is focused on specific disease states
summary of evidence of value of mtms
Summary of Evidence of Value of MTMS
  • Economic
    • Multiple studies have shown positive results on total health care costs, creating a positive return on investment
  • Clinical
    • Multiple studies have indicated improvement in clinical outcomes, specifically in diabetes, asthma, hypertension and dyslipidemia
  • Humanistic
    • The Asheville project has demonstrated reduced employee sick days and increased productivity.

Fera T., Bluml BM, Ellis WM. JAPhA. 2009; 49(3): 383-391.

Isetts, et al., J Am Pharm Assoc. 2008;48(2):203-211

Bunting BA, Cranor CW. JAPhA. 2006; 46:133-147.

Cranor CW, Bunting BA, Christensen DB. J Am Pharm Assoc. 2003;43:173-84.

elements of mtms plan design
Elements of MTMS Plan Design
  • Eligibility
  • Reimbursement structure
  • Member engagement strategy
    • Incentives
eligibility
Eligibility
  • Eligibility for a MTMS benefit can be based on:
    • Number of medications
    • Specific chronic conditions
    • Total amount of prescription expenditures
    • Disease state quality goals
reimbursement structure
Reimbursement Structure
  • Recommend utilizing the MTMS CPT billing codes
  • May use them as defined as time-based codes,

or use a cross-walk relative value scale

establishment of billing codes
Establishment of Billing Codes
  • Three ‘pharmacist only’ CPT professional service codes to bill third-party payers for MTM Services delivered face-to-face between a pharmacist and a patient
    • 99605 is to be used for a first-encounter service (up to

15 minutes)

    • 99606 is to be used for a follow-up encounter with an established patient (up to 15 minutes)
    • 99607 may be used with either 99605 or 99606 to bill additional 15-minute increments
  • Classified as Category 1 and became eligible for use January 1, 2008

Beebe M, Dalton JA, Espronceda M, et. al. Current Procedural Terminology 2009. American Medical Association: Chicago, IL.

slide30

CPT Code Definition of MTMS

  • Medication Therapy Management Services (MTMS) describe face-to-face patient assessment and intervention as appropriate, by a pharmacist 
  • MTMS includes the following documented elements: 
    • review of the pertinent patient history
    • medication profile (prescription and non-prescription)
    • recommendations for improving health outcomes and treatment compliance. 
  • Beebe M, Dalton JA, Espronceda M, et. al. Current Procedural Terminology 2009. American Medical Association: Chicago, IL.
member engagement strategy
Member Engagement Strategy
  • May offer copay reductions or waivers
    • For all medications
    • For medications associated with a targeted medical condition (i.e. diabetes, hypertension, dyslipidemia)
      • Copay waivers for targeted medications and supplies were included in the results of the Asheville Study examples and the Diabetes Ten City Challenge
  • Offer reduced copay (or none) for MTMS
      • Copay waivers for the pharmacist visit were included in the results of the Asheville Study examples and the Diabetes Ten City Challenge

Fera T., Bluml BM, Ellis WM. JAPhA. 2009; 49(3): 383-391.

Isetts, et al., J Am Pharm Assoc. 2008;48(2):203-211

Bunting BA, Cranor CW. JAPhA. 2006; 46:133-147.

Cranor CW, Bunting BA, Christensen DB. J Am Pharm Assoc. 2003;43:173-84.

what s in it for the payer
What’s In It For the Payer?
  • MTMS results in decreased overall healthcare costs
    • Prescription costs will likely increase, but this is compensated by an overall decrease in costs
  • Pharmacists can provide MTMS as a member of the health care team and medical home model
  • Increased member satisfaction
  • Mechanisms for MTMS claims processing are well established through CPT codes
what s in it for the patient
What’s In It For the Patient?
  • MTMS provides patients with improved health outcomes from optimizing medication use
    • This includes decreased emergency department visits and hospitalizations
  • Increased understanding of medications and disease management
  • Improved quality of life
summary
Summary
  • Medications are a standard in the care of chronic diseases
  • Pharmacist delivered Medication Therapy Management Services are well documented to decrease health care costs while increasing the quality of health care